Related Experiment Video
Updated: Jul 11, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending
Sara Whaley1, Josh Sharfstein, Josh Rising
1From the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (SW, JS); and Rising Health Strategies, Washington, DC (JR).
Abstract:
States are set to receive an estimated $56 billion in funds from litigation against opioid manufacturers, distributors, and pharmacies over the next 18 years. Unlike the big tobacco settlements in the 1990s, which were often spent on items unrelated to tobacco use, guardrails set by the opioid settlements require the majority of the funds will be spent on opioid remediation. Nonetheless, state and local jurisdictions still have wide discretion on the types and quality of programs that they fund. Addiction medicine specialists have several opportunities to utilize their expertise to inform the effective investment of opioid settlement dollars.
Related Concept Videos
Analgesia and Pain Management
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Control Governance: Regulatory Bodies and Their Impact

